Population Risk S2.3-1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assess- ment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224 60. S2.3-2. Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hyper- tension and systolic blood pressure of at Least 110 to 115 mmHg, 1990 2015. JAMA. 2017;317:165 82. S2.3-3. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058. S2.3-4. Ford ES. Trends in mortality from all causes and cardiovascular dis- ease among hypertensive and nonhypertensive adults in the United States. Circulation. 2011;123:1737 44. S2.3-5. Cheng S, Claggett B, CorreiaAW, et al. Temporal trends in the popu- lation attributable risk for cardiovascular disease: theAtherosclerosis Risk in Communities Study. Circulation. 2014;130:820 8. S2.3-6. Willey JZ, Moon YP, Kahn E, et al. Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. J Am Heart Assoc. 2014;3:e001106. S2.3-7. Saran R, Li Y, Robinson B, et al. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2015;66 Svii:S1 305. 2.4. Coexistence of Hypertension and Related Chronic Conditions S2.4-1. Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104 9. S2.4-2. Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular dis- ease. N Engl J Med. 2012;366:321 9. S2.4-3. Egan BM, Li J, Hutchison FN, et al. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. 